-
Revamped marketing campaign boosts sales of Alli
GlaxoSmithKline’s Alli is back. And while the brand is still slightly down versus year-ago sales — Alli posted a sales decline of 8.9% to $13.9 million across all channels for the 12 weeks ended Nov. 4, according to SymphonyIRI Group — overall, the category is trending up 15% in quarterly sales increases. The recent resumption of marketing efforts behind Alli coupled with recent New Year’s resolutions should maintain Alli’s position as the top-selling diet-aid tablet, and the only OTC option in the category.
-
Medagate launches first dual network healthcare spending card
ATLANTA — Medagate, a wholly owned subsidiary of InComm Holdings, on Monday announced the launch of the MasterCard Dual Value Health Card, the first dual network healthcare spending card. The Dual Value Health Card enables employers and health plans to combine a member/employee healthcare funding purse with a restricted-spend purse for targeted items and incentives.